Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
S K Kundu(AIDS Clinical Trials Group), T. C. Merigan(Stanford University), Lincoln E. Moses(Centre Hospitalier Universitaire Sainte-Justine), David Katzenstein(Stanford University)
Cited by 55
Related Papers
Educational Measurement.
|Journal of the American Statistical Association|1951|1.7k
Combining independent studies of a diagnostic test into a summary roc curve: Data‐analytic approaches and some additional considerations
|Statistics in Medicine|1993|1.4k
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Therapy for HIV Infection in 1998
|JAMA|1998|1k